CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that Co-Founder and Chief Clinical Officer Dr. Thomas Stegmann will present the keynote address at a free seminar sponsored by the Regenerative Medicine Organization, a Las Vegas based non-profit organization. Dr. Stegmann’s presentation “New Hope for Patients Suffering from Cardiovascular Disease” will discuss the potential benefits of Cardio Vascu-Grow(TM), the active ingredient in CVBT’s drug candidate currently in a U.S. Food and Drug Administration authorized clinical trial that represents a potential new treatment for heart disease. The seminar will occur both at 6:00 p.m. and 8:00 p.m. on Tuesday, September 19, 2006, at the New York Hilton, 1335 Avenue of the Americas, 3rd Floor, New York, New York.
